Page 10 - CUA ESMO 2022
P. 10
Background
• The addition of adjuvant ADT to primary radiotherapy (RT) is a
standard of care in high-risk localized prostate cancer
• Salvage RT is the only potentially curative treatment modality
for biochemical recurrence after radical prostatectomy
• The role for ADT in conjunction with salvage RT is not as well
established